|
|
Opioid-induced respiratory effects: new data on buprenorphine
Albert Dahan
Department of Anesthesiology, Leiden University Medical Center, Leiden, a.dahan{at}lumc.nl
When selecting the appropriate long-acting opioid to treat cancer pain, both analgesic efficacy and safety need consideration. Generally, opioids are well tolerated. However, of opioid-typical adverse events, respiratory depression is especially important because of the risk of a fatal outcome. Although all potent opioid analgesics act via the µ-opioid receptor system, they differ in how they affect respiratory control. Recently, the respiratory effects of fentanyl (1 - 7 µg/kg) and buprenorphine (0.7 - 9 µg g/kg) were compared in healthy opioidnaïve volunteers. Fentanyl produced dose-dependent depression of respiration with apnoea at doses  3 µg/kg, while buprenorphine caused depression that levelled at ~50% of baseline with doses 2 µg/kg. These findings indicate the occurrence of a ceiling in the respiratory depression induced by buprenorphine but not by fentanyl. Surprisingly few studies have addressed the clinically important ability to reverse the respiratory effects of opioids. A recent assessment of the naloxone dose required to reverse 0.2 µg intravenous buprenorphine-induced respiratory depression in healthy opioid-naïve volunteers, found that the accumulated naloxone dose causing 50% reversal of respiratory depression was 1.20 0.32 µg/70 kg (given in 30 min); 80% reversal was observed at 2.500.60 µg/70 kg (given in 30 min). At greater buprenorphine doses, full reversal is observed when the duration of naloxone infusion is increased. These findings indicate the need for a continuous rather than bolus administration of naloxone to reverse the respiratory effects of buprenorphine. In conclusion, buprenorphine is more favourable compared with fentanyl in respect to ventilatory control. Buprenorphine causes limited respiratory depression with a ceiling effect at higher doses, while fentanyl causes dose-dependent respiratory depression with apnoea at high dose levels. In the rare instance of respiratory depression, reversal is possible with a sufficient and continuous infusion of naloxone.
Key Words: apnoea • buprenorphine • ceiling effect • fentanyl • naloxone • opioid • respiratory depression
References
- Martin WR. Pharmacology of opioids . Pharmacol Rev 1983; 35: 283-323 .[Abstract]
- Budd K, Shipton EA. Acute pain, the immune system and opiommunosuppression . Acute Pain 2004; 6: 123-135 .[CrossRef]
- Smith HS. Drugs for pain. Hanley & Belfus Inc , 2003.
- Dahan A, Sarton E, Teppema L, et al. Anesthetic potency and influence of morphine and sevoflurane on respiration in m-opioid receptor knockout mice . Anesthesiology 2001; 94: 824-832 .[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Romberg R, Sarton E, Teppema L, et al. Comparison of morphine-6-glucuronide and morphine on respiratory depressant and antinociceptive responses in wild type and m-opioid receptor deficient mice . Br J Anaesth 2003; 91: 862-870 .[Abstract/Free Full Text]
- Jacobson L, Chabal C, Brody MC. A dose-response study of intrathecal morphine: efficacy, duration, optimal dose, and side effects . Anesth Analg 1988; 67: 1082-1088 .[Web of Science][Medline]
[Order article via Infotrieve]
- Bailey PL, Rhondeau S, Schafer PG, et al. Dose-response pharmacology of intrathecal morphine in human volunteers . Anesthesiology 1993; 79: 49-59; discussion 25A.[Web of Science][Medline]
[Order article via Infotrieve]
- Dahan A, Romberg R, Teppema L, et al. Simultaneous measurement and integrated analysis of analgesia and respiration after an intravenous morphine infusion . Anesthesiology 2004; 101: 1201-1209 .[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Regnard C, Pelham A. Severe respiratory depression and sedation with transdermal fentanyl: four case studies . Palliat Med 2003; 17: 714-716 .[Free Full Text]
- WHO Drug Information. 2004; 18: 275-275 .
- Canadian Adverse Reaction Newsletter 2004; 14-14 .
- Dahan A, Yassen A, Bijl H, et al. Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats . Br J Anaesth 2005; 94: 825-834 .[Abstract/Free Full Text]
- Sporer KA. Buprenorphine: a primer for emergency physicians . Ann Emerg Med 2004; 43: 580-584 .[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Walsh SL, Preston KL, Stitzer ML, et al. Clinical pharmacology of buprenorphine: ceiling effect at high doses . Clin Pharmacol Ther 1994; 65: 569-580 .
- Sarton E, Olofsen E, Romberg R, et al. Sex differences in morphine analgesia: an experimental study in healthy volunteers . Anesthesiology 2000; 93: 1245-1254 .[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Dahan A, Yassen A, Romberg R, et al. Buprenorphine induces ceiling in respiratory depression but not in analgesia . Br J Anaesth 2005; 94: 825-834 .[Abstract/Free Full Text]
- Cowan A. Buprenorphine: new pharmacological aspects . Int J Clin Pract Suppl 2003; 133: 3-8, 23-24 .
- Gal TJ. Naloxone reversal of buprenorphine-induced respiratory depression . Clin Pharmacol Ther 1989; 45: 66-71 .[Web of Science][Medline]
[Order article via Infotrieve]
- Bowdle TA. Pharmacology of analgesia. In Healy TEJ, Knight PR eds. Wylie and Churchill-Davidson’s a practice of anesthesia, seventh edition. Arnold , 2003: 543-563.
- Bijl H, Yassen A, Olofsen E, et al. Full reversal of buprenorphine-induced respiratory depression by the opioid receptor antagonist naloxone . Ned Tijdschr v Anesth (Neth J Anesth) 2006; in press.
- Takahashi M, Sugiyama K, Hori M, Chiba S, Kusaka K. Naloxone reversal of opioid anesthesia: clinical evaluation and plasma concentrations of continuous naloxone infusion after anesthesia with high-dose fentanyl . J Anesth 2004; 18: 1-8 .[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
Palliative Medicine, Vol. 20, No. 8 suppl,
3-8 (2006)
DOI: 10.1191/0269216306pm1126oa
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
|
|
